Correlation Between SAB Biotherapeutics and Tevogen Bio
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Tevogen Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Tevogen Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Tevogen Bio Holdings, you can compare the effects of market volatilities on SAB Biotherapeutics and Tevogen Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Tevogen Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Tevogen Bio.
Diversification Opportunities for SAB Biotherapeutics and Tevogen Bio
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between SAB and Tevogen is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Tevogen Bio Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tevogen Bio Holdings and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Tevogen Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tevogen Bio Holdings has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Tevogen Bio go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Tevogen Bio
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 1.94 times more return on investment than Tevogen Bio. However, SAB Biotherapeutics is 1.94 times more volatile than Tevogen Bio Holdings. It trades about 0.17 of its potential returns per unit of risk. Tevogen Bio Holdings is currently generating about -0.14 per unit of risk. If you would invest 5.00 in SAB Biotherapeutics on August 27, 2024 and sell it today you would earn a total of 1.88 from holding SAB Biotherapeutics or generate 37.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 85.71% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Tevogen Bio Holdings
Performance |
| Timeline |
| SAB Biotherapeutics |
| Tevogen Bio Holdings |
SAB Biotherapeutics and Tevogen Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Tevogen Bio
The main advantage of trading using opposite SAB Biotherapeutics and Tevogen Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Tevogen Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tevogen Bio will offset losses from the drop in Tevogen Bio's long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
| Tevogen Bio vs. Global E Online | Tevogen Bio vs. National CineMedia | Tevogen Bio vs. Zedge Inc | Tevogen Bio vs. Dave Busters Entertainment |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |